4//SEC Filing
Altmeyer Anne 4
Accession 0001193125-25-245262
CIK 0001595097other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:54 PM ET
Size
8.6 KB
Accession
0001193125-25-245262
Insider Transaction Report
Form 4
Altmeyer Anne
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share
2025-10-20$4.80/sh+1,060$5,088→ 7,251 total - Sale
Common Stock, par value $0.0001 per share
2025-10-20$20.50/sh−1,060$21,730→ 6,191 total - Exercise/Conversion
Stock options (right to buy)
2025-10-20−1,060→ 4,247 totalExercise: $4.80Exp: 2032-09-26→ Common Stock (1,060 underlying)
Footnotes (3)
- [F1]This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024.
- [F3]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001947086
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:54 PM ET
- Size
- 8.6 KB